ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies
Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall
Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer
ASCO Begins Practice Certification Program
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Joe Fraumeni, founder of molecular epidemiology, dies at 93
“It’s hard to imagine a world without the presence of this gentle scientific giant.” - The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions” - Early-onset colorectal cancer is behaving like a new, biologically distinct disease, researchers note
One woman’s pregnancy shows how this distinction matters - Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members









